Prudential Financial’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-479
| Closed | -$9K | – | 2747 |
|
|
2022
Q1 | $9K | Hold |
479
| – | – | ﹤0.01% | 2595 |
|
|
2021
Q4 | $9K | Sell |
479
-51
| -10% | -$1.53K | ﹤0.01% | 2620 |
|
|
2021
Q3 | $20K | Buy |
530
+107
| +25% | +$4.75K | ﹤0.01% | 2576 |
|
|
2021
Q2 | $25K | Buy |
423
+22
| +5% | +$1.33K | ﹤0.01% | 2536 |
|
|
2021
Q1 | $27K | Buy |
401
+80
| +25% | +$6.26K | ﹤0.01% | 2473 |
|
|
2020
Q4 | $19K | Buy |
321
+35
| +12% | +$2.39K | ﹤0.01% | 2438 |
|
|
2020
Q3 | $23K | Sell |
286
-56
| -16% | -$4.46K | ﹤0.01% | 2415 |
|
|
2020
Q2 | $21K | Hold |
342
| – | – | ﹤0.01% | 2384 |
|
|
2020
Q1 | $18K | Sell |
342
-2
| -0.6% | -$198 | ﹤0.01% | 2329 |
|
|
2019
Q4 | $42K | Buy |
344
+34
| +11% | +$4.89K | ﹤0.01% | 2402 |
|
|
2019
Q3 | $56K | Sell |
310
-57
| -16% | -$8.03K | ﹤0.01% | 2380 |
|
|
2019
Q2 | $48K | Buy |
367
+31
| +9% | +$5.56K | ﹤0.01% | 2424 |
|
|
2019
Q1 | $82K | Hold |
336
| – | – | ﹤0.01% | 2386 |
|
|
2018
Q4 | $64K | Sell |
336
-6
| -2% | -$1.46K | ﹤0.01% | 2328 |
|
|
2018
Q3 | $112K | Buy |
342
+22
| +7% | +$6.74K | ﹤0.01% | 2373 |
|
|
2018
Q2 | $100K | Buy |
320
+4
| +1% | +$1.22K | ﹤0.01% | 2389 |
|
|
2018
Q1 | $77K | Buy |
316
+4
| +1% | +$1.12K | ﹤0.01% | 2306 |
|
|
2017
Q4 | $94K | Buy |
312
+4
| +1% | +$1.11K | ﹤0.01% | 2298 |
|
|
2017
Q3 | $81K | Buy |
308
+7
| +2% | +$2.02K | ﹤0.01% | 2305 |
|
|
2017
Q2 | $79K | Buy |
301
+4
| +1% | +$1K | ﹤0.01% | 2310 |
|
|
2017
Q1 | $107K | Hold |
297
| – | – | ﹤0.01% | 2288 |
|
|
2016
Q4 | $86K | Hold |
297
| – | – | ﹤0.01% | 2301 |
|
|
2016
Q3 | $101K | Sell |
297
-378
| -56% | -$138K | ﹤0.01% | 2272 |
|
|
2016
Q2 | $287K | Buy |
675
+142
| +27% | +$58.5K | ﹤0.01% | 2126 |
|
|
2016
Q1 | $170K | Buy |
533
+315
| +144% | +$107K | ﹤0.01% | 2210 |
|
|
2015
Q4 | $113K | Sell |
218
-280
| -56% | -$103K | ﹤0.01% | 2188 |
|
|
2015
Q3 | $146K | Buy |
498
+4
| +0.8% | +$1.42K | ﹤0.01% | 2151 |
|
|
2015
Q2 | $194K | Buy |
494
+282
| +133% | +$99.5K | ﹤0.01% | 2146 |
|
|
2015
Q1 | $64K | Buy |
212
+12
| +6% | +$2.93K | ﹤0.01% | 2196 |
|
|
2014
Q4 | $45K | Buy |
+200
| New | +$41.3K | ﹤0.01% | 2172 |
|
|
2014
Q3 | – | Sell |
-284
| Closed | -$63K | – | 2308 |
|
|
2014
Q2 | $63K | Buy |
+284
| New | +$63.2K | ﹤0.01% | 2371 |
|
Other funds holding TXMD
RCMNY
E
GF
Prudential Financial's TXMD Position: Q2 2022 in Review
Prudential Financial sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 479 shares — an estimated $9K sold.
Prudential Financial first reported a position in TXMD in Q2 2014 and held it in 31 quarters. The position peaked at $287K in Q2 2016. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.
- Prudential Financial reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
- Prudential Financial sold 479 TherapeuticsMD shares in Q2 2022, an estimated $9K.
- Prudential Financial first reported a position in TherapeuticsMD in Q2 2014 and held it in 31 quarters.
- Prudential Financial's TherapeuticsMD position peaked at $287K in Q2 2016.
- 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.
Based on Prudential Financial's 13F filing for Q2 2022, filed 15 Aug 2022.